PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTechnetium tc-99m sestamibi
Technetium tc-99m sestamibi
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
63 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324—I25.1—3311017
HyperparathyroidismD006961EFO_0008506E21.3——1146
Primary hyperparathyroidismD049950EFO_0008519E21.0——1124
Myocardial infarctionD009203EFO_0000612I21———123
InfarctionD007238EFO_0009463————123
Diabetes mellitusD003920EFO_0000400E08-E13———213
Type 2 diabetes mellitusD003924EFO_0001360E11———112
HypercalcemiaD006934HP_0003072E83.52———1—1
Type 1 diabetes mellitusD003922EFO_0001359E10———1—1
Thyroid neoplasmsD013964EFO_0003841————1—1
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myocardial ischemiaD017202EFO_1001375I20-I25—33—713
Coronary diseaseD003327———23—49
Parathyroid neoplasmsD010282———12—13
AdenomaD000236———12—13
Parathyroid diseasesD010279—E21.5——1—12
Mucocutaneous lymph node syndromeD009080EFO_0004246M30.3111——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C80—2——24
Heart diseasesD006331EFO_0003777I51.9—1——34
Kidney neoplasmsD007680EFO_0003865C64—1——23
Ovarian neoplasmsD010051EFO_0003893C56—1——12
Lung neoplasmsD008175—C34.9011———2
Uterine cervical neoplasmsD002583———1———1
Cardiovascular diseasesD002318EFO_0000319I98—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C502———1416
Molecular imagingD057054——1————1
Triple negative breast neoplasmsD064726——1————1
GliomaD005910EFO_0000520—1————1
Diffuse intrinsic pontine gliomaD000080443——1————1
Non-small-cell lung carcinomaD002289——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal cell carcinomaD002292EFO_0000376—————22
Chest painD002637—R07.9————22
FatigueD005221—R53.83————11
Myocardial reperfusionD015425——————11
Acute coronary syndromeD054058EFO_0005672—————11
Angina pectorisD000787EFO_0003913I20————11
Unstable anginaD000789EFO_1000985I20.0————11
Ventricular remodelingD020257——————11
IschemiaD007511EFO_0000556—————11
GalactorrheaD005687—O92.6————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 156 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
868 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use